Chularat Hospital PCL (BKK:CHG)
Thailand · Delayed Price · Currency is THB 1.380
+0.010 (0.73%)
May 25, 2026, 12:29 PM ICT
Chularat Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 8,436 | 8,347 | 8,237 | 7,730 | 10,103 | 11,742 |
Other Revenue | 72.39 | 70.51 | 243.52 | 284.13 | 304.57 | 257.29 |
| 8,508 | 8,417 | 8,480 | 8,014 | 10,408 | 11,999 | |
Revenue Growth (YoY) | 1.39% | -0.74% | 5.81% | -22.99% | -13.26% | 119.70% |
Cost of Revenue | 6,019 | 5,974 | 6,068 | 5,631 | 5,908 | 5,882 |
Gross Profit | 2,489 | 2,444 | 2,413 | 2,384 | 4,500 | 6,117 |
Selling, General & Admin | 1,213 | 1,192 | 1,127 | 1,003 | 934.88 | 821.27 |
Operating Expenses | 1,213 | 1,192 | 1,127 | 1,003 | 934.88 | 821.27 |
Operating Income | 1,276 | 1,252 | 1,286 | 1,381 | 3,565 | 5,296 |
Interest Expense | -25.33 | -27.52 | -34.52 | -24 | -16.28 | -21.38 |
Interest & Investment Income | 10.52 | 10.52 | 14.11 | 8.66 | 6.08 | 1.9 |
Earnings From Equity Investments | -15.17 | -13.35 | -20.07 | -19.35 | -1.11 | - |
Pretax Income | 1,246 | 1,222 | 1,245 | 1,346 | 3,554 | 5,276 |
Income Tax Expense | 255.89 | 251.26 | 267.26 | 279.09 | 703.37 | 1,009 |
Earnings From Continuing Operations | 989.85 | 970.25 | 977.96 | 1,067 | 2,850 | 4,267 |
Minority Interest in Earnings | -38.16 | -40.88 | -12.74 | -21.21 | -71.68 | -63.22 |
Net Income | 951.68 | 929.37 | 965.22 | 1,046 | 2,778 | 4,204 |
Net Income to Common | 951.68 | 929.37 | 965.22 | 1,046 | 2,778 | 4,204 |
Net Income Growth | 2.71% | -3.71% | -7.73% | -62.35% | -33.91% | 379.58% |
Shares Outstanding (Basic) | 11,004 | 11,000 | 11,000 | 11,000 | 11,000 | 11,000 |
Shares Outstanding (Diluted) | 11,004 | 11,000 | 11,000 | 11,000 | 11,000 | 11,000 |
EPS (Basic) | 0.09 | 0.08 | 0.09 | 0.10 | 0.25 | 0.38 |
EPS (Diluted) | 0.09 | 0.08 | 0.09 | 0.10 | 0.25 | 0.38 |
EPS Growth | 2.66% | -3.71% | -7.73% | -62.35% | -33.91% | 379.58% |
Free Cash Flow | 823.74 | 985.48 | 1,128 | 987.1 | 1,843 | 3,525 |
Free Cash Flow Per Share | 0.07 | 0.09 | 0.10 | 0.09 | 0.17 | 0.32 |
Dividend Per Share | 0.070 | 0.070 | 0.070 | 0.070 | 0.160 | 0.200 |
Dividend Growth | - | - | - | -56.25% | -20.00% | 300.00% |
Gross Margin | 29.26% | 29.03% | 28.45% | 29.74% | 43.23% | 50.98% |
Operating Margin | 15.00% | 14.87% | 15.16% | 17.23% | 34.25% | 44.13% |
Profit Margin | 11.19% | 11.04% | 11.38% | 13.05% | 26.70% | 35.04% |
Free Cash Flow Margin | 9.68% | 11.71% | 13.30% | 12.32% | 17.71% | 29.38% |
EBITDA | 1,752 | 1,724 | 1,749 | 1,797 | 3,921 | 5,623 |
EBITDA Margin | 20.59% | 20.48% | 20.62% | 22.42% | 37.67% | 46.86% |
D&A For EBITDA | 475.52 | 471.93 | 463.31 | 415.65 | 355.71 | 327.11 |
EBIT | 1,276 | 1,252 | 1,286 | 1,381 | 3,565 | 5,296 |
EBIT Margin | 15.00% | 14.87% | 15.16% | 17.23% | 34.25% | 44.13% |
Effective Tax Rate | 20.54% | 20.57% | 21.46% | 20.73% | 19.79% | 19.12% |
Revenue as Reported | 8,508 | 8,417 | 8,480 | 8,014 | 10,408 | 11,999 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.